pargyline has been researched along with Cardiac Hypertrophy in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment with propranolol and pargyline protected against ISO-induced necrosis and myocardial hypertrophy, but did not influence the ISO-induced depletion of NE stores." | 1.25 | Alterations in norepinephrine pattern in the damaged myocardium in the rat. ( Bhagat, B; Dhalla, NS; Sullivan, JM, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhagat, B | 1 |
Sullivan, JM | 1 |
Dhalla, NS | 1 |
Stanton, HC | 1 |
Bowman, Z | 1 |
Cooper, CM | 1 |
2 other studies available for pargyline and Cardiac Hypertrophy
Article | Year |
---|---|
Alterations in norepinephrine pattern in the damaged myocardium in the rat.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Isoproterenol; Male; Monoamine Oxidase; Myocardium; Necrosi | 1975 |
Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats.
Topics: Animals; Carbon Isotopes; Cardiomegaly; DNA; Female; Glycine; Isocarboxazid; Isoniazid; Isoprotereno | 1970 |